查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1318836

儿科疫苗市场：按技术、疫苗、适应症和最终用户划分 - 全球预测 2023-2030

Pediatric Vaccines Market by Technology, Vaccine, Indication, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球儿科疫苗市场将大幅成长，达到190.7亿美元，年复合成长率为11.55%，预计2030年将达到410.6亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球儿科疫苗市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球儿科疫苗市场规模及预测为何？

2.在预测期内，COVID-19对全球儿科疫苗市场的阻碍因素和影响为何？

3. 在预测期内，全球儿科疫苗市场需要投资哪些产品/细分市场/应用/领域？

4.全球儿科疫苗市场的竞争策略为何？

5. 全球儿科疫苗市场的技术趋势和法律规范是什么？

6.全球儿科疫苗市场主要厂商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球儿科疫苗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 儿科人群感染疾病患者病率增加
      • 疫苗接种的好处包括预防严重和预防将疾病传播给他人。
      • 政府介入儿童疫苗的使用
    • 抑制因素
      • 缺乏强制疫苗接种实施
      • 与儿童疫苗相关的轻微副作用
    • 机会
      • 强大的后期研发管线和新药认证
      • 用于婴儿和儿童免疫的常规疫苗
    • 任务
      • 没有统一的召回或提醒制度，人员短缺。
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章儿科疫苗市场：依技术分类

  • 减毒活病毒
  • 组合
  • 灭活病毒
  • 多醣
  • 重组
  • 亚基
  • 类毒素

第7章依疫苗分類的儿科疫苗市场

  • 单价
  • 多价的

第8章儿科疫苗市场适应症

  • B型流感嗜血桿菌
  • 肝炎
  • 人类乳突病毒
  • 麻疹
  • A型脑膜炎
  • 腮腺炎
  • 肺炎球菌疾病
  • 小儿麻痹
  • 轮状病毒
  • 德国麻疹
  • 破伤风
  • 发烧

第9章儿科疫苗市场：依最终用户分类

  • 医院
  • 儿科诊所
  • 研究机构

第10章美洲儿科疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太儿童疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲儿科疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-030EE4851569

The Global Pediatric Vaccines Market is forecasted to grow significantly, with a projected USD 19.07 billion in 2023 at a CAGR of 11.55% and expected to reach a staggering USD 41.06 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pediatric Vaccines Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pediatric Vaccines Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technology, market is studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids. The Conjugates is projected to witness significant market share during forecast period.

Based on Vaccine, market is studied across Monovalent and Multivalent. The Monovalent is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Haemophilus Influenzae Type B, Hepatitis, Human Papillomavirus , Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever. The Measles is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospital, Pediatric Clinic, and Research Organization. The Hospital is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pediatric Vaccines Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pediatric Vaccines Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pediatric Vaccines Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pediatric Vaccines Market?

4. What is the competitive strategic window for opportunities in the Global Pediatric Vaccines Market?

5. What are the technology trends and regulatory frameworks in the Global Pediatric Vaccines Market?

6. What is the market share of the leading vendors in the Global Pediatric Vaccines Market?

7. What modes and strategic moves are considered suitable for entering the Global Pediatric Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pediatric Vaccines Market, by Technology, 2022 vs 2030
  • 4.3. Pediatric Vaccines Market, by Vaccine, 2022 vs 2030
  • 4.4. Pediatric Vaccines Market, by Indication, 2022 vs 2030
  • 4.5. Pediatric Vaccines Market, by End User, 2022 vs 2030
  • 4.6. Pediatric Vaccines Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
      • 5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
      • 5.1.1.3. Government intervention for the use of pediatric vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of implementation of mandatory vaccination
      • 5.1.2.2. Slight-side effects associated with pediatric vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Strong late-stage pipeline and new drug approvals
      • 5.1.3.2. Routinized vaccines used in immunization of infants and children
    • 5.1.4. Challenges
      • 5.1.4.1. No uniform recall or reminder system and staff shortages
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Pediatric Vaccines Market, by Technology

  • 6.1. Introduction
  • 6.2. Attenuated Live Viruses
  • 6.3. Conjugates
  • 6.4. Inactivated Viruses
  • 6.5. Polysaccharides
  • 6.6. Recombinant
  • 6.7. Subunits
  • 6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine

  • 7.1. Introduction
  • 7.2. Monovalent
  • 7.3. Multivalent

8. Pediatric Vaccines Market, by Indication

  • 8.1. Introduction
  • 8.2. Haemophilus Influenzae Type B
  • 8.3. Hepatitis
  • 8.4. Human Papillomavirus
  • 8.5. Measles
  • 8.6. Meningitis A
  • 8.7. Mumps
  • 8.8. Pneumococcal Diseases
  • 8.9. Polio
  • 8.10. Rotaviruses
  • 8.11. Rubella
  • 8.12. Tetanus
  • 8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Pediatric Clinic
  • 9.4. Research Organization

10. Americas Pediatric Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pediatric Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pediatric Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC VACCINES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 5. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2022 VS 2030 (%)
  • FIGURE 6. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 7. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 8. PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. PEDIATRIC VACCINES MARKET DYNAMICS
  • FIGURE 10. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PEDIATRIC VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 5. PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 13. PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 16. PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 201. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 202. PEDIATRIC VACCINES MARKET LICENSE & PRICING